Juva Life Inc. Share Price Other OTC
Equities
JUVAF
CA48222R1010
Pharmaceuticals
Sales 2021 | 3.87 309.61 | Sales 2022 | 5.76 461.41 | Capitalization | 10.4M 832M |
---|---|---|---|---|---|
Net income 2021 | -11M -881M | Net income 2022 | -10M -801M | EV / Sales 2021 | 8,085,207 x |
Net Debt 2021 | 1.62M 130M | Net Debt 2022 | 7.38M 591M | EV / Sales 2022 | 3,084,662 x |
P/E ratio 2021 |
-2.51
x | P/E ratio 2022 |
-0.99
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 52.48% |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 02/04/19 |
Dan Hughes
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kari A. Gothie
ADM | Chief Administrative Officer | - | 29/05/19 |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 02/04/19 |
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+23.05% | 3.66B | |
+109.78% | 2B | |
+87.30% | 61.69M |